FDA Panel Votes To Recommend Coronavirus Boosters For Older Adults And Individuals At Risk Of Serious Illness

The Washington Post (9/17, Johnson, McGinley, Achenbach) reported, “Expert advisers to the Food and Drug Administration voted unanimously Friday to recommend that the agency authorize a booster shot of the Pfizer-BioNTech coronavirus vaccine six months af...